Pharmaceutical

Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031

The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over the course of the forecast period.

Aug 24, 2023 - 20:00
Diabetic macular oedema market expected to reach $9.6bn across 7MM by 2031
The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over the course of the forecast period.
Read the original article

Tags:

Previous Article

SK Bioscience and Vaxxas partner to develop needle-free typhoid vaccine patch

Next Article

UK life sciences grapple with the job market’s digital dilemma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Karuna Therapeutics files for FDA approval for schizophrenia treatment

Karuna Therapeutics files for FDA approval for schizoph...

Sep 29, 2023

STAT+: Novo acquires Inversago for up to $1 billion, spotlighting troubled weight loss approach

STAT+: Novo acquires Inversago for up to $1 billion, sp...

Aug 11, 2023

STAT+: DeepMind touts AlphaFold’s new skills as protein-folding AI models face off

STAT+: DeepMind touts AlphaFold’s new skills as protein...

Nov 1, 2023